Location: Sydney, Australia
Date:
Event description: Join Novotech at NECTA (New South Wales Early Clinical Trial Alliance) on March 22nd in Sydney, where the drug development community across Australia will gather to exchange ideas. This year's meeting centers on phase 1 dosing, big data and AI, solid tumor CAR-T, and debates whether phases are needed in clinical trials. Novotech is a global full-service CRO focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. Novotech Drug Development Consulting (DDC) is a leading global product development and regulatory strategy group of Novotech that offers end-to-end program development services. From regulatory strategy to clinical oversight, quality consulting to successful regulatory approvals, our experienced teams provide support throughout your project's entire lifecycle. Connect with Novotech at NECTA to explore how our comprehensive services can elevate your clinical development plans. See you there!
Schedule a meeting with our attendees
Meet Our Team
Julie Gargano
Dimity Gransbury
Ann Madrid
Plus experts from our China, Drug Development, and global Commercial teams.